GigaVax ApS: Financial statements 2023
CVR: 41855495
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
GigaVax ApS (CVR 41855495) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -20,484 and a net result of DKK -15,978 compared with DKK -73,872 the year before. Equity in the 2023 report amounted to DKK -75,312.
- Gross Profit
- DKK -20,484
- Profit/Loss
- DKK -15,978
- Equity
- DKK -75,312
- Total Assets
- DKK 190,058
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -20 t. | -16 t. | -75 t. | - |
| 2022 | - | -88 t. | -74 t. | -59 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
GigaVax ApS has published its annual report for 2022. Gross profit came to DKK -88,079, and the net result was DKK -73,872.
As of July 18, 2023, REVISORKOMPAGNIET GODKENDT REVISIONSANPARTSSELSKAB has stepped down as auditor of GigaVax ApS.
About GigaVax ApS
GigaVax ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans-Henrik Kristensen. The board consists of Henrik Pedersen (chair) and Hans-Henrik Kristensen. The company is owned by Hans-Henrik Kristensen, SCIENT. INVEST ApS and Fwd Holding ApS. In 2024, the company reported a gross profit of DKK -7,690 and a net result of DKK -13,849 compared with DKK -15,978 the year before. Equity in the 2024 report amounted to DKK -89,161.